The Role of DL-Methionine Hydroxamate in Modern Antibacterial Development
The escalating challenge of antibiotic resistance necessitates continuous innovation in the field of antibacterial drug development. At the forefront of this research are compounds that target essential bacterial processes. DL-Methionine Hydroxamate, a hydroxamic acid derivative with CAS number 36207-43-9, has emerged as a compound of significant interest due to its potent inhibitory action on bacterial enzymes, particularly peptide deformylase (PDF). NINGBO INNO PHARMCHEM CO.,LTD., as a premier chemical supplier, provides researchers with access to this critical intermediate, empowering the development of next-generation therapeutics.
Peptide deformylase (PDF) is a crucial metalloenzyme found in bacteria responsible for the essential step of removing N-terminal formyl groups from newly synthesized proteins. Inhibition of PDF disrupts bacterial protein synthesis and consequently halts bacterial growth. This makes PDF an attractive target for novel antibacterial agents. DL-Methionine Hydroxamate, with its specific inhibitory profile against PDF, is a vital compound for researchers investigating this pathway.
The efficacy of DL-Methionine Hydroxamate as a PDF inhibitor has spurred extensive research into its structure-activity relationships and the development of more potent analogs. Scientists frequently require high-purity DL-Methionine Hydroxamate to conduct detailed studies, including in vitro assays and structure-based drug design. For those seeking to buy DL-Methionine Hydroxamate, partnering with a reliable manufacturer in China like NINGBO INNO PHARMCHEM CO.,LTD. is essential. We ensure that our product meets the exacting standards required for cutting-edge pharmaceutical research.
The development of new antibacterials is a complex process, and having access to well-characterized chemical building blocks is fundamental. As a trusted pharmaceutical intermediate supplier, we understand the critical nature of compound purity and consistent supply. Our commitment to quality ensures that researchers can rely on our CAS 36207-43-9 for their studies, helping to accelerate the discovery and development of new treatments. We also offer competitive enzyme inhibitor price points to support research budgets.
Beyond its primary role in antibacterial research, DL-Methionine Hydroxamate also finds applications in biochemical studies, contributing to our understanding of metalloenzymes and protein synthesis. Its unique properties make it a versatile tool for various scientific explorations. When you need to source this important compound, consider the advantages of working with NINGBO INNO PHARMCHEM CO.,LTD. We are dedicated to supporting scientific innovation by providing high-quality chemicals and responsive service. Get a quote today and explore how our products can advance your research.
In summary, DL-Methionine Hydroxamate plays a pivotal role in the ongoing efforts to combat antibiotic resistance. Its specific enzyme inhibitory properties make it an invaluable asset in the development of new antibacterial therapies. As a leading supplier of this critical compound, NINGBO INNO PHARMCHEM CO.,LTD. is committed to empowering scientific discovery. Contact us to discuss your needs for DL-Methionine Hydroxamate and other essential research chemicals.
Perspectives & Insights
Alpha Spark Labs
“DL-Methionine Hydroxamate, a hydroxamic acid derivative with CAS number 36207-43-9, has emerged as a compound of significant interest due to its potent inhibitory action on bacterial enzymes, particularly peptide deformylase (PDF).”
Future Pioneer 88
“, as a premier chemical supplier, provides researchers with access to this critical intermediate, empowering the development of next-generation therapeutics.”
Core Explorer Pro
“Peptide deformylase (PDF) is a crucial metalloenzyme found in bacteria responsible for the essential step of removing N-terminal formyl groups from newly synthesized proteins.”